Clinical Trials List
2017-01-20 - 2025-08-15
Phase III
Terminated7
ICD-10C09.8
Malignant neoplasm of overlapping sites of tonsil
ICD-10C09.9
Malignant neoplasm of tonsil, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9146.0
Malignant neoplasm of tonsil
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tsung-Lun Lee Division of Otolaryngology
- 戴世光 Division of Otolaryngology
- 朱本元 Division of Otolaryngology
- Mu-Hsin Chang Division of Radiation Therapy
- Ling-Wei Wang Division of Radiology
- 胡育文 Division of Radiation Therapy
- 羅文良 Division of Oral and Maxillofacial Surgery
- Yuan-Hung Wu Division of Radiation Therapy
- 黃品逸 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- 蔡牧宏 Division of Radiation Therapy
- 劉奕廷 Division of Hematology & Oncology
- 吳沅樺 Division of Radiation Therapy
- 薛尉廷 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- HUAI-CHENG HUANG Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- YA-FANG CHEN Division of Radiology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳彥豪 Division of Hematology & Oncology
- 方富民 Division of Radiation Therapy
- 林偉哲 Division of Radiology
- 劉建廷 Division of Hematology & Oncology
- 李易濰 Division of Radiology
- 黃泰霖 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Cheng-Lung Hsu Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- Li-Yu Lee Division of Others -
- 黃炳勝 Division of Radiation Therapy
- Chia-Hsun Hsieh Division of Hematology & Oncology
- Shu-Hang Ag Division of Radiology
- Tung-Chieh Chang Division of Radiation Therapy
- Tzu-Chen Yen Division of Nuclear Medicine
- 范綱行 Division of Radiation Therapy
- 廖俊達 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
33 participants
-
Global
780 participants
